IRAK2 (Interleukin-1 Receptor-Associated Kinase 2) is a serine/threonine protein kinase that plays a critical role in Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways. It is primarily involved in the innate immune response and neuroinflammation, making it a highly relevant target in neurodegenerative disease research. Unlike IRAK1 and IRAK4, IRAK2 has relatively weak intrinsic kinase activity and functions more as a scaffolding protein that stabilizes the signaling complex while also contributing to downstream activation. @flannagan2012
| Attribute | Value |
|-----------|-------|
| Gene Symbol | IRAK2 |
| Full Name | Interleukin-1 Receptor-Associated Kinase 2 |
| Chromosomal Location | 3p25.3 |
| NCBI Gene ID | 3656 |
| Ensembl ID | ENSG00000134070 |
| UniProt ID | O43187 |
| Protein Family | IRAK family (IRAK2) |
IRAK2 is a key mediator in the TLR/IL-1R signaling cascade:
- Receptor activation: Upon TLR or IL-1R activation by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), IRAK2 is recruited to the receptor complex through interactions with MYD88 adaptor protein
- Complex formation: IRAK2 forms a complex with IRAK4 and MYD88 at the activated receptor
- IRAK4 phosphorylation: IRAK4 phosphorylates IRAK2 on threonine residues
- Downstream signaling: Phosphorylated IRAK2 activates TRAF6, leading to NF-κB and MAPK activation
- NF-κB activation: The IRAK2/TRAF6 pathway leads to IKK activation and NF-κB nuclear translocation
- MAPK activation: IRAK2 also contributes to MAPK (p38, JNK, ERK) signaling pathways
- Inflammatory gene expression: The TLR/IRAK2 pathway drives transcription of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8 @gottipati2008
Unlike IRAK1 and IRAK4 which have robust kinase activity, IRAK2 has relatively weak intrinsic kinase activity:
- Residual kinase activity: Low but detectable autophosphorylation capability
- Scaffolding function: Primary role is as a scaffold for complex assembly
- Activation loop: Contains an activation loop that can be phosphorylated
- Death domain: Contains an N-terminal death domain for protein-protein interactions @kawagoe2009
IRAK2 phosphorylates several downstream substrates:
- TRAF6: Primary substrate, activation of E3 ubiquitin ligase activity
- TAB proteins: TAK1 complex activation
- IRAK1: Cross-phosphorylation
IRAK2 is strongly implicated in Alzheimer's disease through neuroinflammation:
- Elevated expression: IRAK2 expression is significantly elevated in AD brain tissue, particularly in microglia surrounding amyloid plaques
- Amyloid response: IRAK2 is activated by amyloid-beta through TLR4 and CD14
- Genetic association: Genetic variants in IRAK2 have been associated with increased AD risk in some population studies
- Tau pathology: IRAK2-mediated neuroinflammation contributes to tau pathology progression
- Therapeutic targeting: IRAK2 is being explored as a therapeutic target to reduce chronic neuroinflammation in AD @genetic2022
- Microglial activation: IRAK2 drives pro-inflammatory microglial activation (M1 phenotype)
IRAK2 plays a significant role in PD pathogenesis:
- Upregulation: IRAK2 is upregulated in the substantia nigra of PD patients
- TLR4-mediated activation: TLR4-mediated IRAK2 activation contributes to microglial activation and dopaminergic neuron loss
- Genetic susceptibility: IRAK2 polymorphisms may influence PD susceptibility and progression
- Environmental triggers: Pesticide-induced microglial activation involves IRAK2
- α-synuclein aggregation: IRAK2 activation may enhance α-synuclein-induced neurotoxicity @microglial2021
IRAK2 contributes to ALS pathogenesis:
- Elevated expression: IRAK2 expression is elevated in ALS microglia and astrocytes
- Neuroinflammation: IRAK2-mediated inflammation may contribute to motor neuron degeneration
- TDP-43 pathology: The IRAK2 pathway interacts with SOD1 and TDP-43 pathology
- Excitotoxicity: IRAK2 may modulate excitotoxic cell death
- Therapeutic potential: IRAK2 inhibitors may protect motor neurons @irak2024
IRAK2 is implicated in multiple sclerosis:
- Susceptibility: IRAK2 polymorphisms are associated with MS susceptibility
- Demyelination: IRAK2 contributes to demyelination and axonal injury through glial activation
- Blood-brain barrier: IRAK2 activation affects BBB permeability
- EAE models: IRAK2 is essential for experimental autoimmune encephalomyelitis @wang2018
Emerging evidence suggests IRAK2 involvement:
- Neuroinflammation: IRAK2 in FTD-associated neuroinflammation
- TDP-43 pathology: Interaction with TDP-43 proteinopathy
IRAK2 is expressed in:
- Peripheral immune cells: Highest expression in monocytes and macrophages
- Spleen: High expression
- Kidney: Moderate expression
- Liver: Lower expression
- Brain: Expressed in glia
In the brain, IRAK2 is expressed in:
- Microglia: Highest expression, particularly in activated pro-inflammatory microglia
- Astrocytes: Moderate expression, upregulated during neuroinflammation
- Neurons: Low baseline expression, increased in pathological conditions
- Oligodendrocytes: Low expression
Regional expression is highest in:
Small molecule inhibitors:
- Several IRAK2 inhibitors are in development for chronic inflammatory conditions
- Dual IRAK1/IRAK4 inhibitors are also being explored
Anti-inflammatory Therapy:
- Modulating IRAK2 activity may reduce harmful neuroinflammation while preserving beneficial immune responses
- Must balance immune defense against infection risk
Combination Therapy:
- IRAK2 inhibitors may complement disease-modifying therapies targeting protein aggregation
- Potential combination with anti-amyloid or anti-α-synuclein therapies
- Preclinical candidates: Multiple small molecules in preclinical testing
- Natural compounds: Some flavonoids show IRAK2 inhibitory activity
- Repurposing opportunities: Existing anti-inflammatory drugs may act partially through IRAK2
flowchart TD
A["TLR/IL-1R Activation"] --> B["MYD88 Recruitment"]
B --> C["IRAK4 Recruitment"]
C --> D["IRAK2 Recruitment"]
D --> E["IRAK4 phosphorylates IRAK2"]
E --> F["TRAF6 Activation"]
F --> G["TAK1 Activation"]
F --> H["NF-κB Activation"]
G --> I["MAPK Activation"]
H --> J["Pro-inflammatory Gene Transcription"]
I --> J
J --> K["TNF-α, IL-1β, IL-6, IL-8"]
K --> L["Chronic Neuroinflammation"]
L --> M["Neuronal Death"]